Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2015-01-09)Premium Content

Novo Nordisk (NVO)

2015-03-27@09:31:00 ET
Critical Alerts For Bank of America, Novo Nordisk, Infinera Corporation, JC Penney and Realty Income Released By InvestorsObserver (PRN)

2015-03-27@08:55:00 ET
Pharma Stocks Technical Review -- Novo Nordisk, Mallinckrodt, Theravance, Cempra, and Ampio Pharma (PRN)

2015-03-27@08:28:06 ET
Novo Nordisk has the Best Relative Performance in the Pharmaceuticals Industry (NVO, SCLN, TEVA, AKRX, MYL) (F70)

2015-03-27@07:10:32 ET
Novo Nordisk's Onset 1 & Onset 2 Meet Primary Objectives (ZAX)

2015-03-27@04:35:44 ET
Bristol-Myers Squibb Acquires Exclusive License from Novo Nordisk (CLM)

2015-03-26@21:20:52 ET
Novo-Nordisk A/SCorporate Event Announcement Notice (WSH)

2015-03-26@12:47:00 ET
(PRN)

2015-03-26@12:29:46 ET
Novo Nordisk A/S : Novo Nordisk has decided to resubmit the New Drug Applications of Tresiba(r) and Ryzodeg(r) in the US (PMZ)

2015-03-26@12:24:43 ET
Novo Nordisk A/S : Novo Nordisk has decided to resubmit the New Drug Applications of Tresiba(R) and Ryzodeg(R) in the US (HUG)

2015-03-26@08:32:22 ET
Salix Pharmaceuticals is Among the Companies in the Pharmaceuticals Industry with the Best Relative Performance (SLXP, PBH, HSP, NVO, MRK) (F70)

2015-03-25@21:23:49 ET
Novo-Nordisk A/SCorporate Event Announcement Notice (WSH)

2015-03-25@16:11:01 ET
Bristol-Myers Squibb signs license agreement with Novo Nordisk (DTF)

2015-03-25@16:05:11 ET
Zosano Pharma Reports 2014 Financial Results (PMZ)

2015-03-25@13:22:42 ET
Novo Nordisk A/S: Novo Nordisk completes phase 3a trials comparing faster-acting insulin aspart with NovoRapid(R) in people with type 1 and type 2 diabetes (PMZ)

2015-03-25@13:15:20 ET
Novo Nordisk A/S: Novo Nordisk completes phase 3a trials comparing faster-acting insulin aspart with NovoRapid(R) in people with type 1 and type 2 diabetes (HUG)

2015-03-25@08:32:47 ET
Novo Nordisk's Saxenda approved by European Commission (MTO)

2015-03-24@17:47:27 ET
Watch for Novo Nordisk to Potentially Pullback After Gaining 1.40% Yesterday (PSM)

2015-03-24@15:35:50 ET
Recent 52-Week High Exceeded in Shares of Novo Nordisk (NVO) (F71)

2015-03-24@14:20:31 ET
Novo Nordisk Trading Higher on 1.6x Above-Average Volume (NVO) (F82)

2015-03-24@12:32:41 ET
Buyers Accumulate Shares of Novo Nordisk, Up 1.8% (F77)